The bioprinting startup has received the funding through the Western Innovation initiative.

Vancouver-based Aspect Biosystems, which focuses on 3D bioprinting and tissue engineering, has received $2.7m from Canada’s Western Innovation (Winn).

Winn has funded 17 projects in British Columbia so far in 2018, with a total of $20m invested.